View More Recent Stories

Jan 31, 2018 12:24PM Number of Shares and Votes in Orexo
Dec 12, 2017 02:49AM Orexo Discloses More Information About the Improved Market Access Position for Zubsolv® US in 2018
Nov 30, 2017 02:38AM Orexo Publishes Prospectus and Applies for Listing of Bonds on Nasdaq Stockholm
Nov 22, 2017 02:49AM Orexo Completes Early Redemption of Existing Bond Loan
Nov 20, 2017 09:02AM Zubsolv® Receives Authorization for Treatment of Opioid Dependence in Europe
Oct 31, 2017 04:00AM Orexo Issues Bonds of SEK 325 Million and Confirms Fulfilment of Condition Under Notice of Early Redemption
Oct 27, 2017 03:37AM Orexo Announces Conditional Total Redemption of its Senior Unsecured Bonds
Oct 3, 2017 11:56AM Orexo Appoints Nomination Committee and Publishes Financial Calendar 2017/2018
Oct 2, 2017 02:19AM Orexo Signs Asset Purchase Agreement With Gesynta Pharma AB for OX-MPI
Aug 2, 2017 03:27AM Orexo: Zubsolv® Gains Preferred Position on CVS Caremark 2018 Formulary
Jun 30, 2017 12:10PM Number of Shares and Votes in Orexo
Jun 16, 2017 11:53AM Issue and Repurchase of Class C Shares
Jun 2, 2017 02:30AM Orexo Receives USD 2.5 Million Milestone Payment From AstraZeneca as OX-CLI Advances Into Clinical Trials
Apr 6, 2017 12:41PM Report From Orexo AB´s Annual General Meeting, April 6 2017
Mar 1, 2017 02:55AM Orexo Commences Patent Infringement Litigation Against Actavis for Their Generic Versions of Suboxone® and Subutex® Tablets in the US
Feb 20, 2017 02:07AM Orexo Completes Bond Buyback Program
Jan 31, 2017 11:56AM Number of Shares and Votes in Orexo
Dec 21, 2016 02:49AM Orexo Completes Bond Buyback Program
Dec 8, 2016 02:18AM Orexo Appeal Zubsolv® US District Court Decision
Nov 16, 2016 03:08AM Orexo: Favorable outcome from Zubsolv® patent infringement litigation against Actavis
Oct 31, 2016 01:06PM Number of shares and votes in Orexo
Oct 6, 2016 02:11AM Orexo: FDA Approves Unique Low Dosage of Zubsolv®
Sep 30, 2016 12:31PM Number of Shares and Votes in Orexo
Sep 29, 2016 12:08PM Orexo Appoints Nomination Committee and Publishes Financial Calendar 2016/2017
Sep 22, 2016 12:05PM Orexo: Issue and Repurchase of Class C Shares
Sep 2, 2016 02:09AM Orexo Completes 1,080 Patient REZOLV Study and Reports on Improved Treatment of Opioid Dependent Patients
Jun 28, 2016 08:08AM Brexit/EU Referendum Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
View More Recent Stories